Movicol

Macrogol 3350, the active ingredient in Movicol, is an osmotic laxative presented as a powder for oral solution for oral use. It is indicated for the treatment of constipation in adults and children by retaining water in the intestinal lumen, softening stool and facilitating bowel movements.

GNH USA supplies Movicol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent product quality for global healthcare providers through established distribution networks.

Movicol, an osmotic laxative, is used to manage conditions related to impaired bowel motility and hard stools. - Constipation: relief of infrequent or difficult bowel movements by softening stool. - Chronic constipation: long‑term management of persistent constipation when lifestyle measures are insufficient. - Opioid‑induced constipation: alleviation of constipation caused by opioid therapy. - Bowel preparation for diagnostic procedures: softening stool to facilitate colonoscopy. - Constipation associated with metabolic disorders: improves stool consistency in patients with limited mobility.

Movicol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Diarrhea - Abdominal cramps - Increased thirst

Serious or Rare Side Effects: - Severe dehydration - Electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Allergic reactions such as rash or angioedema - Severe abdominal pain - Rectal bleeding - Anaphylaxis (rare)

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in patients with severe renal impairment. - Monitor electrolytes: prolonged use may affect sodium or potassium levels. - Avoid in intestinal obstruction: risk of perforation. - Use caution in elderly patients: higher risk of dehydration. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Movicol can interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Concurrent use with other osmotic laxatives: may cause severe electrolyte disturbances. - Co‑administration with loop diuretics: increased risk of dehydration. - Use with high‑dose mineral supplements: may alter electrolyte balance.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce the efficacy of Movicol. - Proton pump inhibitors: may affect electrolyte absorption. - Oral rehydration solutions: monitor overall fluid balance.